Pelvic Floor Knowledge and Dysfunction in Female Athletes

NCT07209839 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 127

Last updated 2025-11-26

No results posted yet for this study

Summary

The pelvic floor is a complex structure composed of bones, connective tissue, muscles, and nerves that supports the pelvic organs and provides voluntary control and resting tone of the sphincters. Closely related to continence, sexual function, core stabilization, and posture, the pelvic floor muscles-particularly the levator ani with its type 1 and type 2 fibers-ensure both resting tone and rapid responses to sudden increases in intra-abdominal pressure. In women, pelvic floor dysfunctions (including urinary and anal incontinence, pelvic organ prolapse, defecatory and sexual dysfunctions) occur especially during pregnancy, childbirth, and menopause and adversely affect quality of life. Recently, research on pelvic floor muscles and dysfunctions in female athletes has grown, with competing hypotheses suggesting that these muscles may be strong yet overloaded and weakened due to excessive training. Sports that increase intra-abdominal pressure, such as running, weightlifting, and gymnastics, may stress the pelvic floor and elevate dysfunction risk. Various studies have shown high prevalences of urinary and anal incontinence and pelvic organ prolapse in athletes, alongside generally low pelvic floor awareness. However, few studies have examined the relationship between physical activity level, type, and duration with pelvic floor dysfunction and awareness together. The present study aims to investigate the effects of physical activity, demographic characteristics, and sporting experience on pelvic floor dysfunctions and pelvic floor knowledge in female athletes.

Conditions

  • Pelvic Floor
  • Female Athletes
  • Physical Activity
  • Demographic Data

Sponsors & Collaborators

  • Berivan Beril Kılıç

    lead OTHER

Eligibility

Min Age
16 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-10-03
Primary Completion
2025-10-27
Completion
2025-11-10

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07209839 on ClinicalTrials.gov